vagin
infect
common
caus
women
discomfort
complain
occur
prepuberti
girl
women
reproduct
age
postmenopaus
women
vagin
infect
may
symptomat
asymptomat
symptomat
infect
present
erythema
oedema
itchi
burn
pain
vagin
discharg
vulva
may
also
involv
pathogen
respons
vagin
infect
includ
bacteria
fungi
protozoa
bacteri
vaginosi
bv
aerob
vagin
av
candidiasi
common
infect
women
childbear
age
characteris
imbalanc
vagin
microbiota
popul
vagin
discharg
wherea
bv
often
asymptomat
characteris
discharg
typic
fishi
odour
polymicrobi
syndrom
varieti
opportunist
pathogen
bacteria
gardnerella
vaginali
replac
resid
lactobacillu
speci
av
resid
lactobacilli
replac
intestinallyderiv
aerob
microorgan
escherichia
coli
streptococcu
agalactia
staphylococcu
aureu
enterococcu
faecali
highli
symptomat
inflammatori
state
av
typic
present
yellow
smelli
vagin
discharg
bv
av
gener
accompani
vagin
ph
increas
beyond
healthi
vagin
ph
candidiasi
frequent
symptomat
mycot
infect
caus
yeast
candida
albican
pathogen
candida
speci
lifetim
women
expect
experi
least
one
episod
candidainduc
vagin
acut
pruritu
smelli
vagin
discharg
usual
complain
vagin
candidiasi
associ
vagin
discomfort
irrit
vulvar
burn
dyspareunia
dysuria
differ
bv
av
vagin
ph
usual
remain
normal
rang
common
therapeut
strategi
vagin
infect
antibiot
treatment
variabl
sensit
resist
differ
antimicrobi
agent
report
time
thu
challeng
treatment
efficaci
frequent
result
relaps
vagin
pathogen
may
also
surviv
antibiot
format
bacteri
coloni
vagin
epithelium
surfac
name
biofilm
also
report
respons
vagin
infect
recurr
magnitud
gynaecolog
obstetr
consequ
vagin
infect
particularli
sever
pregnant
women
recent
foster
develop
newli
emerg
therapi
includ
either
novel
vagin
deliveri
system
aim
prolong
resid
time
drug
vagin
caviti
novel
antimicrobi
agent
nifuratel
plantderiv
essenti
oil
glycerol
monolaur
silver
exampl
emerg
strategi
good
safeti
profil
silver
well
known
strong
antimicrobi
properti
silverbas
biocid
includ
ionic
silver
form
metal
silver
nanoparticl
antimicrobi
toward
broad
spectrum
gramneg
gramposit
bacteria
fungi
virus
silver
ion
inhibit
microbi
biofilm
format
destabil
polymer
matrix
biofilm
form
last
find
could
clinic
relev
sinc
vagin
infect
sustain
sever
microorgan
form
biofilm
coloni
vitro
studi
firstli
assess
antimicrobi
activ
novel
organ
sucros
octasulf
silver
salt
iaso
interpharm
invest
limit
uk
vagin
pathogen
isol
clinic
case
human
symptomat
vagin
end
sever
vitro
assay
perform
use
differ
growth
cultur
media
incub
ph
valu
afterward
test
antimicrobi
properti
innov
vagin
gel
silso
femm
contain
iaso
among
activ
ingredi
select
activ
ingredi
formul
whole
vagin
gel
includ
kso
potassium
sucros
octasulf
trophic
antibacteri
adhes
properti
sodium
hyaluron
hya
strong
moistur
heal
promot
activ
six
vagin
pathogen
isol
human
clinic
case
symptomat
vagin
infect
name
escherichia
coli
enterobact
aerogen
staphylococcu
aureu
streptococcu
agalactia
gardnerella
vaginali
yeast
candida
albican
includ
studi
strain
cultiv
brain
heart
infus
bhi
oxoid
england
agar
plate
g
vaginali
medium
supplement
fetal
bovin
serum
singl
coloni
pick
transfer
bhi
broth
incub
aerob
atmospher
h
grown
coloni
character
biochem
molecularli
rdna
sequenc
store
fresh
bhi
broth
volvol
glycerol
subsequ
experi
iaso
antimicrobi
activ
test
microtit
plate
method
use
dosedecreas
aqueou
prepar
start
solut
contain
gl
silver
ion
dilut
either
bhi
brain
heart
extract
pepton
glucos
nacl
phosphat
buffer
supplement
fetal
bovin
serum
g
vaginali
lapt
salt
free
medium
pepton
tripton
glucos
yeast
extract
liquid
medium
adjust
ph
valu
addit
hcl
naoh
need
autoclav
media
vagin
pathogen
test
subcultur
three
time
h
allow
adapt
new
environment
condit
fresh
bhi
lapt
medium
differ
start
ph
valu
place
plate
inocul
cfuml
pathogen
coincub
iaso
achiev
final
silver
concentr
mgl
well
optic
densiti
od
measur
nm
carri
baselin
h
incub
kinet
analysi
microorgan
growth
estim
iaso
antimicrobi
activ
express
percent
reduct
pathogen
growth
compar
silverfre
control
cultur
experi
perform
triplic
procedur
perform
insid
dark
cabinet
prevent
chemic
chang
occur
ionic
silver
expos
light
two
independ
experi
perform
triplic
observ
microtit
plate
method
standard
plate
count
appli
quantit
assay
differenti
iaso
microbiocid
microbiostat
activ
one
volum
cultur
pathogen
mix
tube
one
volum
fresh
bhi
broth
ph
supplement
iaso
achiev
final
silver
concentr
mgl
control
prepar
mix
cultur
pathogen
unsuppl
broth
tube
incub
dark
h
mixtur
centrifug
min
pellet
wash
resuspend
salin
solut
suspend
cell
serial
dilut
plate
pour
surfac
bhi
agar
plate
incub
coloni
count
log
reduct
initi
count
taken
bactericid
activ
silso
femm
sf
cm
pharma
limit
uk
aqueou
gel
contain
iaso
mgl
ie
ppm
activ
ingredi
formul
kso
hya
wherea
propylen
glycol
carbopol
ultrez
lubrizol
excipi
gelform
thicken
respect
assess
differenti
contribut
iaso
versu
kso
hya
antimicrobi
properti
whole
vagin
gel
formul
contain
activ
ingredi
iaso
isf
formul
contain
excipi
activ
ingredi
pl
prepar
compar
analysi
due
gel
viscos
antimicrobi
activ
gel
formul
test
solid
agar
plate
first
set
experi
differ
amount
sf
isf
pl
spread
onto
entir
surfac
mm
diamet
bhi
agar
plate
achiev
final
concentr
parallel
plate
contain
correspond
amount
ag
iaso
also
run
plate
left
dri
pour
ml
bhi
medium
previous
inocul
cfu
pathogen
e
coli
c
albican
plate
allow
solidifi
incub
dark
h
anaerob
condit
macroscop
evalu
opac
surfac
growth
describ
opaqu
transpar
transluc
partial
transpar
depend
degre
growth
plate
contain
gel
formul
contain
bhi
agar
use
control
second
set
experi
mg
sf
isf
pl
spot
area
surfac
bhi
agar
plate
previous
adjust
ph
spread
cultur
pathogen
equival
amount
silver
ion
contain
mg
sf
silver
ion
test
drop
directli
iaso
area
agar
surfac
addit
mg
isf
pl
supplement
ionic
silver
use
proper
dilut
iaso
isfag
plag
respect
test
experi
carri
duplic
repeat
twice
plate
incub
dark
h
observ
incub
plate
evalu
sign
growth
inhibit
halo
around
pathogen
spot
result
antimicrobi
activ
iaso
liquid
media
express
mean
two
independ
experi
perform
triplic
standard
deviat
control
plate
bhi
lapt
broth
support
microbi
growth
test
pathogen
highest
effici
ph
gener
iaso
ad
cultur
strong
antimicrobi
activ
observ
figur
show
growth
inhibitori
effect
iaso
express
cultur
prepar
differ
media
differ
start
ph
valu
differ
final
silver
ion
concentr
bhi
lapt
broth
iaso
result
effect
inhibit
bacteri
growth
almost
complet
growth
arrest
pathogen
test
ppm
ag
effect
particularli
evid
ph
lowest
silver
ion
concentr
ppm
ag
microbi
strain
also
differenti
inhibit
growth
depend
broth
ph
use
bhi
minim
bactericid
concentr
silver
ion
mbc
ie
minim
concentr
total
inhibit
growth
mgl
g
vaginali
mgl
bacteri
pathogen
lapt
medium
mbc
mgl
g
vaginali
mgl
e
coli
e
aerogen
mgl
aureu
agalactia
respect
experiment
condit
test
total
growth
inhibit
never
observ
c
albican
bhi
broth
ph
c
albican
significantli
inhibit
iaso
concentr
correspond
ppm
ag
ppm
ag
induc
highest
degre
inhibit
ph
lapt
medium
ph
c
albican
inhibit
mgl
ag
milder
still
signific
inhibit
observ
mgl
ag
ph
worth
note
final
concentr
mgl
ag
signific
antimicrobi
activ
iaso
c
albican
yeast
growth
reduct
observ
lapt
ph
bhi
dose
complet
ineffect
due
small
differ
observ
microbi
growth
bhi
lapt
media
bhi
medium
use
subsequ
experi
besid
start
ph
valu
chosen
mimic
vagin
environ
typic
mani
bacteri
infect
standard
plate
count
assay
differenti
microbiocid
microbiostat
activ
iaso
strong
antimicrobi
activ
observ
bacteri
pathogen
almost
ag
concentr
convers
one
logarithm
drop
cell
number
observ
c
albican
cfuml
control
cfuml
cultur
silver
ion
test
final
ag
concentr
therefor
experiment
condit
iaso
produc
biocid
activ
test
bacteria
microbiostat
effect
c
albican
tabl
summaris
data
antimicrobi
activ
commerci
vagin
gel
formul
sf
compar
isf
miss
iaso
formul
pl
excipi
gel
formul
first
set
experi
increas
amount
gel
spread
surfac
agar
plate
detect
e
coli
c
albican
growth
inhibit
transluc
ie
mg
per
mm
petri
dish
sf
lowest
concentr
capabl
affect
e
coli
c
albican
surfac
growth
therefor
defin
cutoff
concentr
experi
antimicrobi
activ
instead
detect
isf
pl
confirm
antimicrobi
activ
gel
strictli
depend
presenc
iaso
formul
proof
concept
plate
run
parallel
spread
correspond
amount
iaso
express
silver
ion
ag
inhibitori
effect
microbi
growth
observ
iaso
concentr
test
except
ag
ag
iaso
almost
total
inhibit
pathogen
surfac
growth
second
set
experi
sf
isf
pl
antimicrobi
activ
assess
vagin
pathogen
test
spot
cutoff
concentr
plate
surfac
plate
spot
iaso
run
parallel
equival
amount
silver
ion
ag
per
contain
mg
gel
zone
growth
inhibit
observ
pathogen
iaso
sf
spot
agar
surfac
although
differ
induc
iaso
sf
boundari
size
inhibit
halo
observ
among
variou
pathogen
clear
inhibit
zone
regular
boundari
similar
size
observ
agalactia
g
vaginali
clear
area
inhibit
irregular
boundari
observ
e
aerogen
coloni
grow
within
iaso
within
sf
zone
observ
aureu
neither
sf
iaso
complet
inhibit
growth
e
coli
c
albican
h
incub
isf
pl
inhibit
growth
pathogen
interestingli
isf
pl
supplement
proper
amount
iaso
isfag
antimicrobi
effect
restor
differ
observ
halo
form
sf
isfag
pathogen
data
shown
present
studi
assess
vitro
antimicrobi
activ
novel
silver
organ
salt
iaso
innov
vagin
gel
silso
femm
contain
iaso
activ
ingredi
pathogen
isol
vagin
swab
women
symptomat
vagin
iaso
silso
femm
inhibit
growth
test
pathogen
two
cultur
media
use
bhi
lapt
extent
iaso
antimicrobi
efficaci
seem
depend
pathogen
strain
silver
ion
concentr
ph
verifi
natur
iaso
antimicrobi
behaviour
microbiocid
andor
microbiostat
properti
studi
three
differ
concentr
silver
ion
mgl
experiment
condit
three
concentr
display
bactericid
action
bacteria
test
wherea
fungistat
effect
could
observ
c
albican
result
agreement
microtit
plate
assay
perform
bhi
complet
inhibit
bacteri
growth
found
final
silver
ionic
concentr
mgl
decreas
yeast
growth
final
silver
ion
concentr
mgl
find
suggest
bactericid
fungistat
effect
iaso
depend
ionic
silver
concentr
microorgan
term
speci
initi
inoculum
ph
critic
environment
paramet
regul
vagin
ecosystem
imbal
ordinari
vagin
microbiota
usual
caus
vagin
ph
increas
therebi
creat
favor
local
milieu
growth
potenti
pathogen
bacteria
best
knowledg
studi
investig
effect
ph
silver
antimicrobi
effici
avail
literatur
found
ph
may
inde
affect
antimicrobi
activ
iaso
figur
iaso
gener
show
stronger
antimicrobi
activ
ph
higher
physiolog
ph
final
ionic
silver
concentr
higher
mgl
evid
bhi
medium
pathogen
test
observ
clinic
relev
sinc
vagin
ph
usual
find
patient
affect
bacteri
vaginosi
aerob
vagin
also
diagnost
paramet
overal
result
suggest
effect
ph
iaso
efficaci
depend
final
concentr
avail
silver
ion
condit
microbi
growth
pathogen
speci
involv
differ
theoret
expect
influenc
salt
organ
matter
cultur
media
minor
relev
organ
matter
salt
present
cultur
media
could
interfer
antimicrobi
activ
silver
ion
propens
form
complex
silver
ion
therebi
reduc
silver
ion
avail
exert
desir
antimicrobi
activ
instead
slight
differ
found
antimicrobi
activ
iaso
relat
two
differ
media
use
differ
limit
lower
antimicrobi
activ
aureu
agalactia
lapt
result
case
higher
mbc
mgl
silver
ion
lapt
versu
mgl
bhi
stronger
antimicrobi
activ
c
albican
lapt
compar
mbc
instead
found
media
g
vaginali
mgl
ionic
silver
e
coli
e
aerogen
mgl
ionic
silver
differ
composit
salt
organ
compound
two
media
well
divers
suscept
silver
ion
differ
pathogen
speci
might
explain
result
support
present
observ
previou
studi
also
found
equal
mbc
e
coli
mgl
ionic
silver
higher
mbc
aureu
mgl
ionic
silver
even
studi
chemicallyproduc
silver
nanoparticl
use
sourc
silver
ion
determin
mbc
perform
differ
experiment
condit
similar
result
relev
anoth
studi
surfactantbas
temperaturesensit
gel
contain
silver
nanoparticl
test
mbc
mgl
found
aureu
mbc
mgl
found
e
coli
pseudomona
aeruginosa
studi
g
vaginali
result
sensit
iaso
activ
media
ph
test
mbc
mgl
ionic
silver
far
know
studi
test
suscept
g
vaginali
silver
ion
avail
literatur
experiment
condit
could
find
minim
concentr
total
inhibit
growth
c
albican
nevertheless
iaso
bhi
cultur
ph
abl
decreas
yeast
growth
rate
rang
respect
control
concentr
mgl
silver
ion
respect
reduc
c
albican
growth
also
observ
lapt
ph
decreas
found
concentr
mgl
silver
ion
higher
concentr
mgl
silver
ion
reduct
yeast
growth
high
accord
previou
experiment
studi
toxic
effect
silver
candida
speci
depend
loss
membran
integr
membran
potenti
consequ
reduct
cell
viabil
furthermor
recent
shown
silver
also
exert
antifung
effect
candida
biofilm
colloid
silver
nanoparticl
report
affect
matrix
composit
structur
candida
biofilm
doseindepend
manner
silver
believ
exert
antimicrobi
properti
fungi
virus
protozoa
accord
mechan
action
similar
antibacteri
effect
bind
biolog
molecul
contain
thiol
amino
carboxyl
imidazol
phosphat
group
ionic
silver
form
inhibit
vital
activ
microbi
enzym
protein
atp
product
glucos
oxid
silver
ion
make
complex
microbi
dna
rna
microbi
membran
damag
silvergener
free
radic
data
indic
silver
proper
condit
effect
antifung
agent
antimicrobi
activ
vagin
gel
silso
femm
concern
amount
high
mg
per
need
achiev
visibl
inhibit
microbi
growth
experiment
condit
suggest
vagin
gel
could
less
effect
correspond
amount
ag
iaso
discrep
ascrib
viscou
natur
gel
formul
slow
diffus
silver
ion
matrix
therebi
appar
decreas
amount
silver
avail
microbi
growth
inhibit
end
worth
note
silverfre
gel
formul
result
inact
pathogen
find
suggest
sf
ingredi
iaso
exert
antimicrobi
activ
moreov
mg
gel
formul
spot
agar
plate
silso
femm
correspond
amount
iaso
express
silver
ion
similarli
abl
form
halo
pathogen
test
wherea
silverfre
gel
formul
total
unabl
form
inhibit
halo
addit
proper
amount
silver
ion
silverfre
gel
formul
promptli
recov
antimicrobi
activ
provid
still
evid
fact
iasosderiv
silver
ion
respons
antimicrobi
effect
silso
femm
nevertheless
silso
femm
display
stronger
antimicrobi
activ
aureu
g
vaginali
c
albican
well
known
organ
biofilm
coloni
make
resist
sever
drug
therapi
unexpect
result
could
merit
assess
find
differ
strain
display
differenti
sensit
iaso
alon
silso
femm
could
suggest
ingredi
gel
formul
ie
kso
hya
may
synerg
iaso
antimicrobi
activ
antiadhes
properti
although
abl
assess
experiment
condit
complex
dynam
hostbacteria
relationship
includ
biofilm
format
host
factor
pathogenresid
microbiota
interact
etc
howev
abl
evalu
vitro
potenti
effect
antimicrobi
agent
iaso
vagin
pathogen
conclus
vitro
result
highlight
antimicrobi
activ
iaso
patent
silver
salt
sucros
octasulf
number
bacteri
strain
involv
onset
symptomat
vagin
well
yeast
c
albican
respons
one
frequent
vagin
fungal
infect
data
obtain
studi
indic
also
silso
femm
vagin
gel
formul
contain
iaso
may
display
import
antimicrobi
effect
bacteri
yeast
pathogen
suggest
potenti
role
novel
formul
prevent
andor
treatment
feminin
vagin
infect
adjunct
drug
therapi
